Glenmark’s GRC 54276 receives FDA acceptance for clinical trial in cancer patients
Glenmark Pharmaceuticals’ subsidiary, Glenmark Specialty, has received acceptance from the US Food and Drug Administration (FDA) on its Investigational New…
Where health news comes full circle!